Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004377
Filing Date
2021-11-12
Accepted
2021-11-12 16:07:03
Documents
77
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q flxn-20210930.htm   iXBRL 10-Q 2590263
2 EX-10.2 flxn-ex10_2.htm EX-10.2 555541
3 EX-10.3 flxn-ex10_3.htm EX-10.3 293391
4 EX-31.1 flxn-ex31_1.htm EX-31.1 11746
5 EX-31.2 flxn-ex31_2.htm EX-31.2 11901
6 EX-32.1 flxn-ex32_1.htm EX-32.1 9677
  Complete submission text file 0000950170-21-004377.txt   11755610

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flxn-20210930_def.xml EX-101.DEF 228593
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flxn-20210930.xsd EX-101.SCH 62355
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flxn-20210930_lab.xml EX-101.LAB 536480
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flxn-20210930_pre.xml EX-101.PRE 401663
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flxn-20210930_cal.xml EX-101.CAL 60668
12 EXTRACTED XBRL INSTANCE DOCUMENT flxn-20210930_htm.xml XML 2330430
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36287 | Film No.: 211403439
SIC: 2834 Pharmaceutical Preparations